How Psychedelic Research Will Transform Mental Health Treatment | Upfront Summit 2018

Charles Grob and Bob Jesse sit down with Joe Green to discuss the reemergence of psychedelic research. Charles Grob, M.D., is Professor of Psychiatry and Pediatrics at the UCLA School of Medicine and Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center. He conducted the first government-approved study of MDMA, and was the principal investigator of an international biomedical psychiatric research project in the Brazilian Amazon of the plant, ayahuasca. He is currently conducting an investigation of the effects of psilocybin on anxiety in cancer patients. Robert Jesse is convenor of the Council on Spiritual Practices. Through CSP, he was instrumental in creating the psilocybin research team at the Johns Hopkins University, and he is one of its co-investigators. Prior to CSP, he worked as a consultant in information technology for AT&T Bell Labs and others, then in several capacities for Oracle Corporation, lastly as a vice president of business development.